OptiMed Health Partners and PotentiaMetrics Launch a Disruptive Cancer Outcomes Platform
MyCancerJourney empowers patients with actionable information to improve the patient's experience and outcomes in cancer treatment.
KALAMAZOO, Mich., October 17, 2018 (Newswire.com) - OptiMed Health Partners, a Kalamazoo, Michigan based Specialty Pharmacy and Infusion healthcare provider announced it has partnered with PotentiaMetrics data and artificial intelligence company, to launch MyCancerJourney, a shared decision-making platform for cancer treatments.
MyCancerJourney was developed with researchers at Washington University School of Medicine in St. Louis to provide patient-specific survival estimates and improve the health outcomes of patients with cancer.
We are thrilled to work alongside OptiMed... Together, we will provide personalized information to patients and address the high cost of cancer treatment in a meaningful way.
Robert Palmer, CEO of PotentiaMetrics
OptiMed Health Partners will be able to enhance the value of their oncology care program for their patients and clients by offering this personalized medical information platform for their patients. Patients will have the ability to make better treatment decisions with their healthcare providers and improve their treatment experience during their cancer treatment journey.
“We are thrilled to work alongside OptiMed. Both of our companies are focused on personalized approaches to healthcare that lead to improved outcomes and better value. Together, we will provide personalized information to patients and address the high cost of cancer treatment in a meaningful way,” says Robert Palmer, CEO of PotentiaMetrics.
“We are really excited to include this innovative platform (MyCancerJourney) to our arsenal of tools used to improve patient outcomes in cancer and add real value to the healthcare ecosystem. I have seen many analytical and AI healthcare solutions but MyCancerJourney is one of the very few solutions that lives up to the hype and gets me excited about the future of healthcare,” says OptiMed CEO Andy Reeves.
About PotentiaMetrics: PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs. To learn more about PotentiaMetrics, visit: www.potentiametrics.com or to learn more about MyCancerJourney, visit: www.mycancerjourney.com.
About OptiMed Health Partners: OptiMed Health Partners, based in Kalamazoo, Michigan; is dually accredited by the Accreditation Commission for Health Care (ACHC) and URAC, specializes in treatments for rare and chronic conditions, such as: rheumatoid arthritis, Hemophilia, multiple sclerosis, oncology, psoriasis and more. The organization has decades of experience offering personalized solutions that bring meaningful value to stakeholders. To learn more about OptiMed Health Partners, visit: www.optimedspecialtyrx.com.
Source: OptiMed Health Partners
Related Media
